Judith van Deutekom

Judith van Deutekom

UNVERIFIED PROFILE

Are you Judith van Deutekom?   Register this Author

Register author
Judith van Deutekom

Judith van Deutekom

Publications by authors named "Judith van Deutekom"

Are you Judith van Deutekom?   Register this Author

44Publications

749Reads

6Profile Views

Dose-dependent pharmacokinetic profiles of 2'-O-methyl phosphorothioate antisense oligonucleotidesin mdx mice.

Nucleic Acid Ther 2013 Jun 2;23(3):228-37. Epub 2013 May 2.

Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/nat.2012.0398DOI Listing
June 2013

Design and analysis of effects of triplet repeat oligonucleotides in cell models for myotonic dystrophy.

Mol Ther Nucleic Acids 2013 Mar 19;2:e81. Epub 2013 Mar 19.

1] Department of Cell Biology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands [2] Prosensa Therapeutics B.V., Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mtna.2013.9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615819PMC
March 2013

Development of antisense-mediated exon skipping as a treatment for duchenne muscular dystrophy.

Ann N Y Acad Sci 2009 Sep;1175:71-9

Duchenne Muscular Dystrophy Genetic Therapy Group, Department of Human Genetics, Leiden University, Medical Center, Leiden, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2009.04973.xDOI Listing
September 2009

Antisense-mediated exon skipping to correct IL-12Rbeta1 deficiency in T cells.

Blood 2009 May 3;113(19):4548-55. Epub 2009 Mar 3.

Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-12-196220DOI Listing
May 2009

Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.

Hum Mutat 2009 Mar;30(3):293-9

Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.20918DOI Listing
March 2009

Assessment of the feasibility of exon 45-55 multiexon skipping for Duchenne muscular dystrophy.

BMC Med Genet 2008 Dec 1;9:105. Epub 2008 Dec 1.

DMD Genetic Therapy Group, Department of Human Genetics, Leiden University, Medical Center, Postzone S4-P, PO Box 9600, 2300RC, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://bmcmedgenet.biomedcentral.com/articles/10.1186/1471-2
Publisher Site
http://dx.doi.org/10.1186/1471-2350-9-105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2611974PMC
December 2008

The therapeutic potential of antisense-mediated exon skipping.

Curr Opin Mol Ther 2008 Apr;10(2):140-9

Leiden University Medical Center, Department of Human Genetics, Zone S4-P, PO Box 9600, 2300 RC Leiden, the Netherlands.

View Article

Download full-text PDF

Source
April 2008

Generation and characterization of transgenic mice with the full-length human DMD gene.

J Biol Chem 2008 Feb 13;283(9):5899-907. Epub 2007 Dec 13.

Center for Human and Clinical Genetics, Leiden University Medical Center, Postal Zone S4-P, PO Box 9600, 2300 RC Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M709410200
Publisher Site
http://dx.doi.org/10.1074/jbc.M709410200DOI Listing
February 2008

Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy.

BMC Med Genet 2007 Jul 5;8:43. Epub 2007 Jul 5.

Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2350-8-43DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1931584PMC
July 2007

Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons.

Mol Ther 2006 Sep 6;14(3):401-7. Epub 2006 Jun 6.

DMD Genetic Therapy Group, Center for Human and Clinical Genetics, Leiden University Medical Center, RC Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2006.02.022DOI Listing
September 2006

Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule.

Muscle Nerve 2006 Aug;34(2):135-44

Leiden University Medical Center, Department of Human Genetics, P.O. Box 9600, 2300 RC Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/mus.20586
Publisher Site
http://dx.doi.org/10.1002/mus.20586DOI Listing
August 2006

Gene expression profiling to monitor therapeutic and adverse effects of antisense therapies for Duchenne muscular dystrophy.

Pharmacogenomics 2006 Apr;7(3):281-97

Leiden University Medical Center, Center for Human and Clinical Genetics, Room S-04-003, Postbus 9600, 2300 RC Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14622416.7.3.281DOI Listing
April 2006

Gene therapy: the 'pro-sense' approach to Duchenne muscular dystrophy.

Eur J Hum Genet 2005 May;13(5):518-9

Center for Human and Clinical Genetics, Leiden University Medical Center, Wassenaarseweg 72, 2333 AL Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.ejhg.5201381DOI Listing
May 2005

Large-scale gene expression analysis of human skeletal myoblast differentiation.

Neuromuscul Disord 2004 Sep;14(8-9):507-18

Center for Human and Clinical Genetics, Leiden University Medical Center, Wassenaarseweg 72, 2333 AL Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S096089660400092
Publisher Site
http://dx.doi.org/10.1016/j.nmd.2004.03.008DOI Listing
September 2004

Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense.

Am J Hum Genet 2004 Jan 16;74(1):83-92. Epub 2003 Dec 16.

Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1181915PMC
http://dx.doi.org/10.1086/381039DOI Listing
January 2004

Advances in Duchenne muscular dystrophy gene therapy.

Nat Rev Genet 2003 Oct;4(10):774-83

Center for Human and Clinical Genetics, Leiden University Medical Center, Wassenaarseweg 72, 2333 AL Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrg1180
Publisher Site
http://dx.doi.org/10.1038/nrg1180DOI Listing
October 2003

Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients.

Hum Mol Genet 2003 Apr;12(8):907-14

Center for Human and Clinical Genetics, Leiden University Medical Center, Wassenaarseweg 72, 2333 AL Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddg100DOI Listing
April 2003

Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy.

Neuromuscul Disord 2002 Oct;12 Suppl 1:S71-7

Department of Human Genetics, Leiden University Medical Center, Wassenaarseweg 72, 2333 AL Leiden, The Netherlands.

View Article

Download full-text PDF

Source
October 2002